INmune Bio, Inc. (INMB)
1.21
-0.02
(-1.63%)
USD |
NASDAQ |
Apr 02, 16:00
1.215
0.00 (0.00%)
After-Hours: 20:00
INmune Bio Shareholders Equity (Quarterly) : 23.52M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AngioDynamics, Inc. | 173.36M |
| Omeros Corp. | -121.23M |
| Precipio, Inc. | 14.56M |
| PDS Biotechnology Corp. | 9.252M |
| Sangamo Therapeutics, Inc. | -14.27M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.35M |
| Total Liabilities (Quarterly) | 8.827M |
| Debt to Equity Ratio | 0.044 |
| Current Ratio | 3.551 |
| Net Debt Paydown Yield | 0.91% |